Menu
GeneBe

22-44679840-C-T

Variant summary

Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong

The NM_001198721.2(PRR5):c.41C>T(p.Ser14Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000744 in 1,598,822 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/17 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. S14P) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.000039 ( 0 hom., cov: 33)
Exomes 𝑓: 0.000078 ( 0 hom. )

Consequence

PRR5
NM_001198721.2 missense

Scores

1
13

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: -0.516
Variant links:
Genes affected
PRR5 (HGNC:31682): (proline rich 5) This gene encodes a protein with a proline-rich domain. This gene is located in a region of chromosome 22 reported to contain a tumor suppressor gene that may be involved in breast and colorectal tumorigenesis. The protein is a component of the mammalian target of rapamycin complex 2 (mTORC2), and it regulates platelet-derived growth factor (PDGF) receptor beta expression and PDGF signaling to Akt and S6K1. Alternative splicing and the use of alternative promoters results in transcripts encoding different isoforms. Read-through transcripts from this gene into the downstream Rho GTPase activating protein 8 (ARHGAP8) gene also exist, which led to the original description of PRR5 and ARHGAP8 being a single gene. [provided by RefSeq, Nov 2010]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_benign. Variant got -2 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.024033576).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
PRR5NM_001198721.2 linkuse as main transcriptc.41C>T p.Ser14Leu missense_variant 2/10
PRR5NM_001017528.3 linkuse as main transcriptc.-11+11035C>T intron_variant
PRR5NM_001017529.3 linkuse as main transcriptc.-152+11035C>T intron_variant

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
PRR5ENST00000403581.5 linkuse as main transcriptc.41C>T p.Ser14Leu missense_variant 2/102 P85299-5
PRR5ENST00000006251.11 linkuse as main transcriptc.-11+2600C>T intron_variant 2 A1P85299-3
PRR5ENST00000432186.5 linkuse as main transcriptc.-11+11035C>T intron_variant 2

Frequencies

GnomAD3 genomes
AF:
0.0000394
AC:
6
AN:
152188
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000196
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.0000294
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.000130
AC:
28
AN:
215296
Hom.:
0
AF XY:
0.000152
AC XY:
18
AN XY:
118526
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.000284
Gnomad ASJ exome
AF:
0.000213
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.000332
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000851
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000781
AC:
113
AN:
1446516
Hom.:
0
Cov.:
28
AF XY:
0.0000863
AC XY:
62
AN XY:
718194
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.000281
Gnomad4 ASJ exome
AF:
0.0000774
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.000275
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.0000498
Gnomad4 OTH exome
AF:
0.000117
GnomAD4 genome
AF:
0.0000394
AC:
6
AN:
152306
Hom.:
0
Cov.:
33
AF XY:
0.0000537
AC XY:
4
AN XY:
74474
show subpopulations
Gnomad4 AFR
AF:
0.00
Gnomad4 AMR
AF:
0.000196
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.0000294
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.000110
Hom.:
0
Bravo
AF:
0.0000567
ExAC
AF:
0.000103
AC:
12

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsOct 22, 2021The c.41C>T (p.S14L) alteration is located in exon 2 (coding exon 1) of the PRR5 gene. This alteration results from a C to T substitution at nucleotide position 41, causing the serine (S) at amino acid position 14 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Benign
-0.52
T
BayesDel_noAF
Benign
-0.68
Cadd
Benign
3.0
Dann
Benign
0.54
Eigen
Benign
-1.3
Eigen_PC
Benign
-1.4
FATHMM_MKL
Benign
0.0025
N
LIST_S2
Benign
0.47
T
M_CAP
Benign
0.0015
T
MetaRNN
Benign
0.024
T
MetaSVM
Benign
-1.0
T
MutationTaster
Benign
1.0
N;N;N
PROVEAN
Benign
-0.23
N
REVEL
Benign
0.039
Sift
Pathogenic
0.0
D
Vest4
0.14
MutPred
0.14
Loss of glycosylation at S14 (P = 0.0076);
MVP
0.043
MPC
0.16
ClinPred
0.081
T
GERP RS
-1.8
gMVP
0.16

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs765335057; hg19: chr22-45075720; API